2. AGENDA
o SCIO Introduction
• SCIO Concept
• SCIO Impacts on Clinical Trials
o BBCR Consulting
• BBCR Values
• BBCR Method
• Experienced Team
2
3. BBCR Consulting is the 1ST Strategic Clinical Innovation Organization
“Strategy and Roadmap for cost-efficiency and risk-management in
clinical trials from pre-clinical to market.”
SCIO Concept
3
5. 5
Phase I Phase II Phase III Approval MarketPre-clinicalDiscovery
Traditional Drug Development Process
Pharmaceutical industry has been developing drug this way for decades; people believe it to be the RIGHT way.
Clinical Tactics
6. 6
Phase I Phase II Phase III Approval MarketPre-clinicalDiscovery Pre-IND
• Regulatory Strategy
• Clinical Strategy
• Clinical/Regulatory
Roadmap
Innovative Drug Development Process
Pre-Clinical
Data
Regulatory
Medical
Information
Marketing
Analysis
KoLs Feedbacks
TIMING
INFORMATION
8. Only Pre-clinical Data
Clinical Strategy (SCIO)
Pre-clinicalDiscovery
Phase I Phase II Phase III
Clinical Tactics (CRO)
• Pre-clinical Data
• Medical Information
• Regulatory Information
• Marketing Analysis
• KoL’s Feedback
• Data Interpretation
• Medical Evaluation
• Regulatory Pathfinding
• Marketing Understanding
• Strategy Formation
Cost-Effective
Clinical Trials
• Regulatory Strategy
• Clinical Strategy
• Clinical/Regulatory
Roadmap
• Simplify Clinical Research
• Customize Clinical Strategy
• Manage Risk
9. 9
BBCR The First SCIO
BBCR CONSULTING is the First SCIO that
• Has a comprehensive understanding of the importance of strategy in clinical trials
• Has a seasoned Board of Advisors and a robust industrial network to provide
supports
• With highest care and professionalism, we Customizes clinical and regulatory
strategy for each life science product to ensure its best opportunity to succeed
• Devises and standardizes SCIO procedures to ensure the best quality services
provided, and thus cost-effective clinical trials being realized
15. 15
INTEGRITY
INNOVATION
NETWORK
Regulatory Strategy
and Regulators’
Feedbacks
Customize Clinical
Strategy Prior to First-
In-Man
Streamline Trial Design
for Cost-Efficiency and
Risk Management
Clinical/Regulatory
Roadmap for Better
Resources Allocation
Regulatory
Uncertainties
Universal Step-by-step
Clinical Development
for Different Products
Clinical Development
Complexity and
Associated Risks
Difficulty in Planning
Resources
Challenges Solutions
21. Lori Perreira Zahra Shahrokh Wade Fox
PhD
Board of Advisor
• Reimbursement
strategy
• Orphan
• Gene Therapy
Board of Advisor
• CMC
• Biologics
• Small Molecule
• Biotechnology
Product
Board of Advisor
• Market Analysis
• Medical Devices
• Medical
Technology
22. CONTACT US
Find us! Drop Your Questions Online!
Location
1 Broadway, Cambridge
MA, USA 02142
Phone
+1(617)401-2327
Email
INFO@BBCRConsulting.com
You Ask! We Answer!
For an immediate help, we created
“You Ask We Answer” Section on our
website to provide further assistance
with any question you may have.
www.BBCRConsulting.com
22